<?xml version="1.0" encoding="UTF-8" standalone="yes"?><Drug id="67682" name="MK-8719"><HDS>No Development Reported</HDS><RegulatoryDesignations><RegulatoryDesignation id="1">Orphan Drug</RegulatoryDesignation></RegulatoryDesignations><Actions><Action id="1051" type="primary">Unspecified enzyme modulator</Action><Action id="284" type="secondary">Nootropic agent</Action><Action id="4155" type="secondary">Imaging agent</Action><Action id="7211" type="secondary">CNS diagnostic agent</Action></Actions><Indications><Indication id="14" type="secondary">Alzheimers disease</Indication><Indication id="1998" type="secondary">Progressive supranuclear palsy</Indication></Indications><Entities><Entity>Chemical</Entity></Entities><OriginatorCompany id="1055950">Alectos Therapeutics Inc</OriginatorCompany></Drug>